A citation-based method for searching scientific literature




W O Creutzfeldt, N Kleine, B Willms, C Orskov, J J Holst, M A Nauck. Diabetes Care 1996
Times Cited: 260




List of shared articles



Times cited


Regulation of glucagon secretion by incretins.
J J Holst, M Christensen, A Lund, J de Heer, B Svendsen, U Kielgast, F K Knop. Diabetes Obes Metab 2011
90

Persistent C-peptide: what does it mean?
Massimo Pietropaolo. Curr Opin Endocrinol Diabetes Obes 2013
7

Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
Christian S Frandsen, Thomas F Dejgaard, Henrik U Andersen, Jens J Holst, Bolette Hartmann, Birger Thorsteinsson, Sten Madsbad. Diabetes Obes Metab 2017
14


Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016
9

Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls.
Karin Zibar, Jadranka Knežević Ćuća, Kristina Blaslov, Tomislav Bulum, Lea Smirčić-Duvnjak. Ann Clin Biochem 2015
4

Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
M M Smits, L Tonneijck, M H A Muskiet, M H H Kramer, D L Cahen, D H van Raalte. Diabetes Obes Metab 2016
39

Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression.
Olga Bloch, Efrat Broide, Gilad Ben-Yehudah, Dror Cantrell, Haim Shirin, Micha J Rapoport. J Diabetes Res 2015
4

GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
24

Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects.
Jonatan I Bagger, Magnus F G Grøndahl, Asger Lund, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2021
0

The alpha-cell as target for type 2 diabetes therapy.
Mikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, Filip K Knop. Rev Diabet Stud 2011
30

Complications of diabetes therapy.
Sarah D Corathers, Shawn Peavie, Marzieh Salehi. Endocrinol Metab Clin North Am 2013
12



The potential of incretin-based therapies in type 1 diabetes.
Chen S Suen, Paul Burn. Drug Discov Today 2012
19

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
David S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, Asger Lund, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop. Int J Mol Sci 2019
13



Gastrointestinal effects of extra-virgin olive oil associated with lower postprandial glycemia in type 1 diabetes.
Lutgarda Bozzetto, Antonio Alderisio, Gennaro Clemente, Marisa Giorgini, Francesca Barone, Ettore Griffo, Giuseppina Costabile, Claudia Vetrani, Paola Cipriano, Angela Giacco,[...]. Clin Nutr 2019
5